90-Second Read: EU Moves To Secure Emergency Antiviral Supplies As Hantavirus Cases Spread

EU governments accelerate antiviral stockpiling as rising Hantavirus infections trigger concerns over public health preparedness across member states. The European Commission has announced the emergency distribution of an experimental antiviral treatment for Hantavirus to France, Spain and the Netherlands as health authorities respond to a growing outbreak linked to a cruise ship. Health authorities have confirmed 13 Hantavirus cases connected to a cruise ship believed to be at the centre of the outbreak.

Japanese pharmaceutical company Fujifilm Pharmaceuticals donated 1,400 tablets of the antiviral medication to support the emergency response. Patients are currently receiving treatment in France, Spain and the Netherlands, while additional cases have also been reported in Switzerland, the United States and South Africa. Hantaviruses are primarily spread through contact with infected rodents and can lead to severe respiratory or kidney-related illnesses in humans.

The World Health Organization estimates that up to 100,000 Hantavirus infections occur globally every year. Authorities across Europe say investigations and monitoring efforts are continuing as health agencies work to contain the spread of the virus and prevent further fatalities. European officials said the first consignments of favipiravir,a drug considered a possible treatment option for Hantavirus infections are now being delivered to the affected countries following urgent requests for medical support.